(Press-News.org) ROCHESTER, Minn. -- A new Mayo Clinic study found that nerve inflammation may cause the pain, numbness and weakness following surgical procedures that is known as postsurgical neuropathy. The development of postsurgical neuropathies is typically attributed to compression or stretching of nerves during surgery. This new research shows that, in some cases, the neuropathy is actually caused by the immune system attacking the nerves and is potentially treatable with immunosuppressive drugs. The study was published in this month's issue of Brain.
Postsurgical neuropathy is an uncommon complication of surgery. Peripheral nerves are the extensive network of nerves that link the brain and spinal cord (the central nervous system) to all other parts of the body. When damaged by stretching, compression or inflammation, the peripheral nerve injury can interfere with communication between the brain and the rest of the body (muscles and sensation are controlled by the nerve). Individuals with postsurgical neuropathy may experience loss of sensation, pain and muscles weakness.
"It is important that a person with postsurgical inflammatory neuropathy receive a diagnosis and treatment quickly. Understanding the role of inflammation in these patients' neuropathy can lead to appropriate immunotherapy and improvement of neurological symptoms and impairments," says P. James Dyck, M.D., a Mayo Clinic neurologist and senior author of this study.
As part of the research, Dr. Dyck and a team of Mayo Clinic researchers selected 23 patients who developed neuropathy within 30 days of a surgical procedure. According to Dr. Dyck, the neuropathy of these 23 patients did not make sense in terms of being caused by stretching or compression because the nerves damaged were usually in a different part of the body from the surgical site or the neuropathy occurred at least a few days after the surgery was over. The surgical procedures were orthopedic, abdominal, chest or dental. All the patients received a nerve biopsy, of which 21 demonstrated increased inflammation. Seventeen patients were treated over a three-month period with immunotherapy, and in all cases with follow-up the neuropathy impairments improved.
"This is exciting for patients because it allows for appropriate identification and accurate treatment of postsurgical neuropathy. Without showing inflammation on the nerve biopsies, we would have been unable to know the cause of the neuropathy," says Nathan Staff, M.D., Ph.D., a Mayo Clinic neurologist and the first author of this study.
"It is logical for patients to believe that it was the surgeon's fault that they developed a neuropathy because it occurred after the surgery," says Dr Dyck. "However, in these cases, we have strong evidence that the neuropathies were not the surgeon's fault but were caused by the immune system attacking the nerves."
###
Other members of the Mayo Clinic research team included JaNean Engelstad, Christopher Klein, M.D., Kimberly Amrami, M.D., Robert Spinner, M.D., Peter Dyck, M.D., Mark Warner, M.D., and Mary Warner, M.D.
About Mayo Clinic
For more than 100 years, millions of people from all walks of life have found answers at Mayo Clinic. These patients tell us they leave Mayo Clinic with peace of mind knowing they received care from the world's leading experts. Mayo Clinic is the first and largest integrated, not-for-profit group practice in the world. At Mayo Clinic, a team of specialists is assembled to take the time to listen, understand and care for patients' health issues and concerns. These teams draw from more than 3,700 physicians and scientists and 50,100 allied staff that work at Mayo Clinic's campuses in Minnesota, Florida, and Arizona; and community-based providers in more than 70 locations in southern Minnesota, western Wisconsin and northeast Iowa. These locations treat more than half a million people each year. To best serve patients, Mayo Clinic works with many insurance companies, does not require a physician referral in most cases and is an in-network provider for millions of people. To obtain the latest news releases from Mayo Clinic, go to www.mayoclinic.org/news. For information about research and education, visit www.mayo.edu. MayoClinic.com (www.mayoclinic.com) is available as a resource for your general health information.
END
The water in the canals and irrigation channels in the L'Albufera Natural Park in Valencia contain cocaine, ecstasy and a further six drugs. This has been confirmed by a study carried out by researchers from the University of Valencia (UV), who have issued a warning about the continued presence of these substances on wildlife and human health.
"The results confirm the presence of drugs such as cocaine, amphetamines, codeine, morphine and cannabis in the surface waters of the L'Albufera National Park at levels ranging between 0.06 and 78.78 nanograms/litre", Yolanda Picó, ...
Children conceived by in vitro fertilization (IVF) perform at least as well as their peers on academic tests at all ages from grade 3 to 12, according to a new University of Iowa study.
In fact, the study, published in the October issue of the journal Human Reproduction, found that children who were conceived by IVF actually scored better than age- and gender-matched peers on the Iowa Test of Basic Skills and the Iowa Test for Educational Development (ITBS/ED).
"Our findings are reassuring for clinicians and patients as they suggest that being conceived through IVF ...
What if there was a drug that could completely eliminate airborne disease transmission that occurs when someone coughs? Researchers at the University of Alberta believe they have found a way to achieve this.
The idea behind this work came from Malcolm King and his research associate Gustavo Zayas, who work in the Division of Pulmonary Medicine at the U of A's Faculty of Medicine & Dentistry. King and Zayas developed a drug that, when inhaled, would reduce or eliminate the amount of droplets, called bioaerosol, coming out of the mouth when a disease-infected person coughs. ...
Scientists are reporting the development and successful initial testing of a new form of methotrexate — the mainstay anticancer drug — designed to be given as nose drops rather than injected. It shows promise as a more effective treatment for brain cancer, they say. The report appears in ACS' Molecular Pharmaceutics, a bi-monthly journal.
Tomotaka Shingaki and colleagues note that brain cancer is difficult to treat, partly because current anticancer drugs have difficulty reaching the brain. That's because the so-called blood-brain barrier (a protective layer of cells ...
We've all heard the saying about people who can't walk and chew gum at the same time, but it turns out that walking and talking is difficult enough, especially for people with Parkinson's disease who are at increased risk for falls with injury.
A new Florida State University study found that older adults with Parkinson's disease altered their gait — stride length, step velocity and the time they spent stabilizing on two feet — when asked to perform increasingly difficult verbal tasks while walking. But the real surprise was that even older adults without a neurological ...
The antibacterial ingredient in some soaps, toothpastes, odor-fighting socks, and even computer keyboards is pointing scientists toward a long-sought new treatment for a parasitic disease that affects almost two billion people. Their report on how triclosan became the guiding light for future development of drugs for toxoplasmosis appears in ACS' monthly Journal of Medicinal Chemistry.
In the study, Rima McLeod and colleagues point out that toxoplasmosis is one of the world's most common parasitic infections, affecting about one-third of the world population, including ...
Researchers from the Cardiac & Vascular Institute at NYU Langone Medical Center will present at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 scientific symposium on September 21-25, 2010 in Washington, DC. They will be available for interviews during the conference.
Louis Miller, MD
Interventional Cardiology Fellow, Department of Medicine, Leon H. Charney Division of Cardiology at NYU Langone Medical Center
Wednesday, September 22, 2010
Presenter
•Very Long-term Clinical Follow-up After Fractional Flow Reserve-Guided Coronary Revascularization, ...
An unusual substance known as "dry water," which resembles powdered sugar, could provide a new way to absorb and store carbon dioxide, the major greenhouse gas that contributes to global warming, scientists reported at the 240th National Meeting of the American Chemical Society. The powder shows bright promise for a number of other uses, they said. It may, for instance, be a greener, more energy-efficient way of jump-starting the chemical reactions used to make hundreds of consumer products. Dry water also could provide a safer way to store and transport potentially harmful ...
COLUMBIA, Mo. – Although obesity is a major risk factor for disease, much of the threat may be associated with the metabolic (or cardiometabolic) syndrome, a cluster of risk factors related to diabetes and heart disease. Losing weight can improve health and reduce many of these risk factors. However, many people struggle to keep the weight off long-term. Now, researchers at the University of Missouri have found that people who perform resistance training while regaining weight can help maintain strides in reducing their risks for chronic disease.
"Long-term weight loss ...
Imagine devices that capture electricity from the air — much like solar cells capture sunlight — and using them to light a house or recharge an electric car. Imagine using similar panels on the rooftops of buildings to prevent lightning before it forms. Strange as it may sound, scientists already are in the early stages of developing such devices, according to a report at the 240th National Meeting of the American Chemical Society.
"Our research could pave the way for turning electricity from the atmosphere into an alternative energy source for the future," said study ...
